Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation. (Q53270176)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Tjalling Bosse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Carien L Creutzberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ronald van Eijk

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Ina M Jürgenliemk-Schulz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jan J Jobsen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ludy C H W Lutgens

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Elzbieta M van der Steen-Banasik

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Natalja T Ter Haar

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Vincent T H B M Smit

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

15 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

466-473

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

Geographic and temporal variations in cancer of the corpus uteri: Incidence and mortality in pre- and postmenopausal women in Europe

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

7 January 2021

Endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

The role of radiotherapy in endometrial cancer: current evidence and trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Emerging therapeutic targets in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Biologic markers in endometrial cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Molecular profiling of endometrial malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Molecular Screening for Hereditary Nonpolyposis Colorectal Cancer: A Prospective, Population-Based Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Microsatellite Instability and Epigenetic Inactivation ofMLH1and Outcome of Patients With Endometrial Carcinomas of the Endometrioid Type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

The phosphoinositide 3-kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Phosphatidylinositol-3-OH kinase as a direct target of Ras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Oncogenic PI3K and its role in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

PI3K pathway alterations in cancer: variations on a theme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

The Synergistic Effect of Conditional Pten Loss and Oncogenic K-ras Mutation on Endometrial Cancer Development Occurs via Decreased Progesterone Receptor Action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

p53-mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

Combinatorial patterns of somatic gene mutations in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.05.012

10.1016/J.YGYNO.2012.05.012

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609107%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference